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Abstract - Omi/HtrA2, a proapoptotic mitochondrial serine protease, is involved in both caspase-dependent and caspase-
independent apoptosis. A growing body of evidence indicates that Omi/HtrA2 plays an important role in the pathogenesis 
of a variety of ischemia-reperfusion (I/R) injuries. However, the role of Omi/HtrA2 in renal injuries that occur in neonates 
with asphyxia remains unknown. The present study was designed to investigate whether Omi/HtrA2 plays an important 
role in the types of renal injuries that are induced by neonatal postasphyxial serum. Human renal proximal tubular cell 
line (HK-2) cells were used as targets. A 20% serum taken from neonates one day after asphyxia was applied to target cells 
as an attacking factor. We initially included control and postasphyxial serum-attacked groups and later included a ucf-101 
group in the study. In the postasphyxial serum-treated group, cytosolic Omi/HtrA2 and caspase-3 expression in HK-2 
cells was significantly higher than in the control group. Moreover, the concentration of cytosolic caspase-3 was found to 
be markedly decreased in HK-2 cells in the ucf-101 group. Our results suggest both that postasphyxial serum has a potent 
apoptosis-inducing effect on HK-2 cells and that this effect can be partially blocked by ucf-101. Taken together, our re-
sults demonstrate for the first time that postasphyxial serum from neonates results in Omi/HtrA2 translocation from the 
mitochondria to the cytosol, where it promotes HK-2 cell apoptosis via a protease activity-dependent, caspase-mediated 
pathway.
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INTRODUCTION
Asphyxia is one of the major factors that can cause 
death in neonates during the perinatal period. The 
essence of asphyxia is hypoxia and ischemia, which 
can lead to damage in almost every organ in the 
body. Several studies have indicated that injury to 
the organs of postasphyxial neonates was associ-
ated with ischemia/reperfusion. Neonatal sequelae, 
in many cases, may be accounted for by perinatal 
asphyxia damage to organs. As the kidneys are very 
sensitive to oxygen deprivation (renal injury may 
occur within 24 h of a hypoxic ischemic episode) re-
nal damage has a higher incident rate in asphyxiated 
neonates than any other type of hypoxic ischemia-
related injury, occurring in more than 50% of neo-
natal asphyxia cases (Gupta et al., 2005). However, 
the precise mechanism of renal injury in postas-
phyxial neonates is still unknown. Understanding 
this mechanism could lead to the development of 
more efficient drugs to prevent cases of asphyxia 
from developing renal injury in newborns. Omi/
HtrA2 is the mammalian homolog of the prokaryo-
tic HtrA protein. Omi/HtrA2 is a nuclear-encoded 
mitochondrial  serine  protease  and  is  expressed 
generally in almost every tissue and organ of the 436 Y. ZHANG ET AL.
body (Rami et al., 2010). Omi/HtrA2 is formed as a 
precursor in the cytoplasm, where it is then trans-
located to the mitochondria. In the mitochondria 
it is processed to its mature form via the removal 
of  an  amino-terminal  domain  (amino  acids  1  to 
133), which exposes the AVPS motif. Upon induc-
tion of apoptosis by cellular stresses, mature Omi/
HtrA2 is released from the mitochondria into the 
cytoplasm, where it binds to the baculovirus IAP 
repeat domain of IAPs via its AVPS sequence mo-
tif. Following a specific cleavage and degradation of 
the IAPs, Omi/HtrA2 initiates caspase-dependent 
apoptosis.  Omi/HtrA2  is  also  able  to  induce  ap-
optosis  in  human  cells  in  a  caspase-independent 
protease  pathway  (Verhagen  et  al.,  2002).  Previ-
ous studies have demonstrated that apoptosis is in-
volved in ischemia/reperfusion renal injuries (Zhao 
et al., 2009). Recent studies from several different 
researchers have independently demonstrated that 
Omi/HtrA2 plays an important role in ischemia/
reperfusion injuries. Althaus et al. (2007) reported 
that focal cerebral ischemia/reperfusion results in 
Omi/HtrA2  translocation  from  the  mitochondria 
to the cytosol, where it participates in neuronal cell 
death. Prior to ischemia treatment with ucf-101, the 
specific inhibitor of Omi/HtrA2 reduced both the 
infarct size and the number of apoptotic cells in the 
focal cerebral ischemia/reperfusion in animal mod-
els.  Hui-Rong  Liu  and  colleagues  demonstrated 
that myocardial ischemia/reperfusion significantly 
increased cytosolic Omi/HtrA2 content and mark-
edly increased  apoptosis  (Liu  et  al.,  2005).  Omi 
promotes cardiomyocyte apoptosis via a protease 
activity-dependent,  caspase-mediated  pathway. 
Treatment  with  ucf-101  exerts  significant cardio-
protective effects. The aim of the present study was 
to investigate the effect of Omi/HtrA2 on the renal 
injury that occurs in postasphyxial neonates and to 
explore further the mechanisms involved.
MATERIALS AND METHODS
Cell culture
Human kidney proximal tubular cell line (Ameri-
can  Type  Culture  Collection)  HK-2  cells  were 
grown  in  DMEM (GIBCO,  Carlsbad,  CA)  sup-
plemented  with  10%  fetal  bovine  serum  (FBS) 
(Hyclone, Logan, UT), 50 U/ml penicillin, 50 µg/
ml  streptomycin (GIBCO),  and  15  mM  HEPES, 
at 37°C in an atmosphere of 95% air and 5% CO2. 
The cells were passaged weekly by trypsinization 
(0.25% trypsin, 0.02% EDTA) after formation of a 
confluent monolayer. The cultured cells were placed 
in serum-free media 24 h before stimulation and 
were divided into a control group, a postasphyxial 
serum-attacking group, and a ucf-101 group. The 
cells of the control group were grown in a normal 
nutritive medium. The cells of the postasphyxial 
serum-attacking group were grown in a medium 
with 20% postasphyxial serum. The cells of the ucf-
101 group were treated with ucf-101 (10 µmol/L) 
and  grown  in  20%  postasphyxial  serum.  During 
the preliminary study, we only examined the con-
trol group and the postasphyxial serum-attacking 
group to investigate whether Omi/HtrA2 was in-
volved in postasphyxial serum-induced injury to 
the human kidney proximal tubular cell line HK-2 
cells. In the next stage of our study, we included 
the ucf-101 group to determine the intracellular 
signal transduction pathway of Omi/HtrA2 in such 
injuries. Cells from all groups were harvested and 
assayed after 24 h of treatment.
Preparation of postasphyxial serum in neonates
Neonates (mean gestational age, 37-40 weeks) with 
neonatal asphyxia (Apgar score lower than 7 points 
at 1 minute) admitted to our neonatal intensive care 
unit  (NICU)  between  March  2007and  December 
2007 were enrolled in this study. The parents of the 
neonates gave informed consent for their partici-
pation. None of the patients was administered im-
mune depressants or exposed to infectious disease. 
Blood was aspirated from the femoral vein within 
24 h of birth (5 ml from each, anticoagulated with 
Liquemine, about 100 ml in total), then the serum 
was  gathered  by  3000  rpm  centrifugation  for  20 
min. The serum was inactivated in a thermostatic 
water bath at 56°C. The serum was filtered and ad-
justed to 200 ml/L by DMEM medium (Zhao et al., 
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Determination of cell viability
Cell viability was determined by MTT assay. Expo-
nentially growing HK-2 cells from each group were 
seeded in 96-well culture plates in serum-free me-
dium at optimal density. After 24 h of incubation, the 
cells were treated as described above. After 24 h, 20 
µl (5 g/L) MTT (Sigma) solution was added to each 
well. After 4 h of incubation, the supernatant was re-
moved and 150 µl DMSO was added to each well and 
swung for 10 min. The optical density at 590 nm was 
determined with an enzyme linked immunosorbent 
assay (ELISA) reader. The results were calculated as 
mean values of eight wells per treatment group.
Detection of the expression of Omi/HtrA2  
and caspase-3
The expression of Omi/HtrA2 and caspase-3 in cy-
toplast  was  detected  by  SP  immunocytochemical 
staining. Immunostaining was carried out accord-
ing to the standard-procedure (SP) method and the 
manufacturer’s  instructions.  Cells  were  incubated 
overnight  with  the  primary  antibody  at  4°C.  The 
same process with PBS instead of primary antibody 
was used as a control. After incubation with the sec-
ondary antibody at 37°C for 10 min and then DAB 
staining, cells were mounted and observed under a 
microscope. Five high-power fields were randomly 
selected. The positive cells appeared brownish-yel-
low in the cytoplast area. The expression of Omi/
HtrA2 was determined by counting the number of 
positive cells among 200 cells. The expression of cas-
pase-3 was analyzed with the Image-Pro Plus6.0 Im-
age Analyzing System.
Confocal microscopy for Omi/HtrA2 translocation
Cells  cultured  on  glass  cover  slips  in  orifice  were 
incubated with MitoTracker Red 580 (1:50000 dilu-
tion) for 20 min at 37°C in the dark. The cells were 
then fixed on cover slips with 4% paraformaldehyde 
(15 min, room temperature) and washed with PBS 
followed by a permeabilization step with 0.1% Triton 
X-100 in PBS for 15 min at room temperature. After 
several washes with PBS, the cover slips were incu-
bated sequentially with blocking buffer for 20 min at 
room temperature, an anti-human Omi/HtrA2 rab-
bit polyclonal antibody for 1 h at 37°C (5µg/mL), and 
secondary antibody (goat anti-Rb IgG/FITC) diluted 
in blocking buffer (1:150) for 30 min at 37°C in the 
dark. The cover slips were washed with PBS several 
times and mounted onto glass slides (VWR) using 
glycerin.  Omi/HtrA2  translocation  was  observed 
by confocal microscopy. The images were acquired 
in confocal microscope at excitation and emission 
wavelengths of 579 nm and 495 nm, respectively.
Flow cytometric analysis of cell apoptosis
Cell apoptosis was determined by flow cytometry af-
ter staining with propidium iodide (PI). HK-2 cells 
(at least 1×106 per sample) from each group were 
harvested by trypsinization (0.25% trypsin), washed 
by PBS, and fixed in 70% pre-cooled ethanol. The 
tubes containing the cells were stored at 4°C for 24 
h. The cells were washed by centrifugation at 2000 
rpm for 5 min in PBS and stained with PI solution 
(0.05g/L, 5g/L RNase A, 10g/L Triton X-100) in the 
dark for 40 min at 37°C. Cells were then resuspended 
in PBS and centrifuged at 2000 rpm for 5 min. before 
being resuspended in 500 μl PBS for flow cytometric 
analysis.
Statistical analyses
All parameters were presented as mean±SEM (x±S). 
The translocation and expression of Omi/HtrA2 be-
tween groups were analyzed via T test. The other data 
among groups were analyzed using a one-way ANO-
VA followed by a mean comparison using a post hoc 
LSD test. Probabilities of 0.05 or less were considered 
statistically significant. The statistical analyses were 
performed using SPSS 10.0 software.
RESULTS
Changes in morphology and viability of HK-2 cells
Under  inverted  microscopy,  HK-2  cells  from  the 
control group showed normal morphology with tight 
connections  to  neighboring  cells  (Fig.  1A).  Com-438 Y. ZHANG ET AL.
pared to those of the control group, the cells from 
the  postasphyxial  serum-attacking  group  assumed 
an off-normal rounded or ellipsoid appearance. The 
refraction rate was lower and contour was enhanced. 
Vacuoles, lipid droplets, and granulation appeared in 
the cytoplasm. There was a great deal of cell debris in 
the accrescent intercellular space (Fig. 1B). Relative 
to those of the postasphyxial serum-attacking group, 
the changes in morphology of the HK-2 cells of the 
ucf-101-treated  group  were  clearly  improved  (Fig. 
1C).
Relative to the control group (0.47±0.02), the cell 
viability (optical density, OD) was significantly de-
creased in the postasphyxial serum-attacking group 
(0.22±0.02).  Relative  to  the  postasphyxial  serum-
attacking group, cell viability was clearly increased 
in the ucf-101-treated group (0.36±0.02, P<0.05) but 
not to the same level as the control group (Fig. 2). 
Effects of postasphyxial serum on Omi/HtrA2  
expression in HK-2 cells
Several studies have reported that Omi/HtrA2 plays 
an  important  role  in  post-ischemic  organ  injury 
(Bhuiyan and Fukunaga, 2007; Saito et al., 2004). Fol-
lowing ischemia/reperfusion in the kidney, the pro-
teolytic activity of Omi/HtrA2 is markedly upregulat-
ed (Faccio et al., 2000). To investigate whether Omi/
HtrA2 was involved in postasphyxial serum-induced 
injury to HK-2 cells, we examined the level of expres-
sion of Omi/HtrA2 in HK-2cells by SP immunocy-
tochemical staining. As shown in Fig. 2, Omi/HtrA2 
was stained inaurate or yellow-brown and appeared 
localized in the cytoplasm. The percentage of control 
group cells expressing Omi/Htra2 was 9.00±2.50% 
(Fig. 3A). After postasphyxial serum challenge, the 
percentage  of  the  postasphyxial  serum-attacking-
group  Omi/Htra2-positive  cells  increased  remark-
ably (25.15±3.50%, P < 0.05) (Fig. 3B).
Effects of postasphyxial-serum on Omi/HtrA2  
translocation from mitochondria to cytoplasm
The mature form of Omi/HtrA2 is localized in the 
mitochondria and may have a distinct function in-
volved in the maintenance of mitochondrial home-
ostasis (Jones et al., 2003). In the cytoplasm, mature 
Omi/HtrA2  can  induce  apoptosis  in  human  cells, 
Fig. 1. The effect of ucf-101 on the morphology of HK-2 cells treated with postasphyxial serum (inverted microscopy×400). A - control 
group; B - postasphyxial serum-attacking group; C - ucf-101-treated group.
A B C
Fig. 2. The effect of postasphyxial serum on the cell viability of 
HK-2 cells. Cell viability was determined by MTT assay. The 
control group shows the highest cell viability of all three groups. 
After  postasphyxial  serum  challenge,  the  cell  viability  of  the 
control group decreased remarkably but was partly reversed by 
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either in a caspase-independent manner through its 
protease activity or in a caspase-dependent manner. 
The key step in this apoptotic pathway is the release 
of  Omi/Htra2  from the  mitochondrial  intermem-
brane space. To confirm that the Omi/HtrA2 pro-
tein is translocated from mitochondria to cytoplasm 
in HK-2 cells treated with postasphyxial serum, we 
compared the fluorescence-staining pattern of cells 
stained with Omi/HtrA2 antibodies and MitoTrack-
er Red 580. The results of the two staining patterns 
were almost identical in the control group, indicating 
that Omi/HtrA2 is localized predominantly in the 
mitochondria in normal HK-2 cells (Fig. 4C1). The 
two staining patterns were distinctive in the postas-
phyxial serum-attacking group, indicating that Omi/
HtrA2 is translocated from the mitochondrial inter-
membrane space to the cytoplasm (Fig. 4C2).  
A1
A2
A B
B1
B2
C1
C2
Fig. 3. Postasphyxial serum-induced changes in expression of 
Omi/HtrA2 in HK-2 cells. The level of expression of Omi/HtrA2 
was detected by SP immunocytochemical staining. The percent-
age of cells expressing Omi/HtrA2 is small in the control group 
(Fig. 3A). After postasphyxial serum challenge, the percentage 
of postasphyxial serum-attacking-group cells expressing Omi/
HtrA2 increased remarkably (Fig. 3B).
Fig.4. The effects of postasphyxial serum on the translocation of Omi/HtrA2 in human renal tubular cell (HK-2). Confocal microscope 
images of HK-2 cells (1. Control group, 2. postasphyxial serum-attacking group) stained with anti-Omi/HtrA2 (green) and MitoTracker 
Red 580 (red). Merged images from A1 and B1 are shown in C1. A2 and B2 are shown in C2. In the control group, Omi/HtrA2 protein 
staining colocalized with MitoTracker staining (C1). After exposure to postasphyxial serum, the two staining patterns were distinctive 
(C2).440 Y. ZHANG ET AL.
Effects of postasphyxial serum on apoptosis 
 in HK-2 cells
Apoptosis plays an important role in the pathogen-
esis of a variety of ischemia/reperfusion (I/R) inju-
ries. We postulate that apoptosis is associated with 
postasphyxial serum-induced injury to HK-2 cells. 
Apoptosis of HK-2cells was evaluated by quantita-
tive determination of apoptosis using flow cytomet-
ric DNA analysis following propidium iodide (PI) 
staining. The data were presented as the percentage 
of apoptotic cells. As shown in Fig. 4, the proportion 
of cells undergoing apoptosis increased from fewer 
than 15% in the control group (Fig. 5A) to 36% af-
ter being attacked by postasphyxial serum (Fig. 5B, 
P<0.05). The proportion of cells undergoing apopto-
sis decreased from 36% in the postasphyxial serum-
attacking group to 26% after ucf-101 treatment (Fig. 
5C, P<0.05). 
The effect of postasphyxial serum on caspase-3  
expression in HK-2 cells
The  caspase  family  is  closely  connected  with 
many apoptotic processes. In the caspase family, 
caspase-3 is a common executer of apoptosis (Thorn-
berry and Lazebnik, 1998). Multiple lines of evidence 
have demonstrated that caspase-3 plays a vital role 
in I/R injury. To confirm that caspase-3 participates 
in  postasphyxial  serum-induced  injury  to  HK-2, 
we examined the level of expression of caspase-3 in 
HK-2cells. As shown in Fig. 5, caspase-3 was inau-
rate or yellow-brown and appeared localized in the 
cytoplasm  of  HK-2  cells.  After  being  attacked  by 
postasphyxial serum, the level of expression of cas-
pase-3 was significantly increased, as indicated by 
the stronger staining in the postasphyxial serum-at-
tacking group (Fig. 6B) relative to the control group 
(Fig. 6A, P < 0.01). After treatment with ucf-101 (10 
µmol/L), the expression of caspase-3 was significant-
ly decreased (Fig. 6C) relative to the postasphyxial 
serum-attacking group (P<0.05).
DISCUSSION
It  has  been  reported  that  ischemia/reperfusion 
induces apoptosis in many cells through different 
mechanisms. As a mitochondrial serine protein, 
mature Omi/HtrA2 is localized in mitochondria. 
Once released into the cytosol following apopto-
sis stimuli, it promotes cell death by antagoniz-
ing IAPs (in a caspase-dependent fashion) and via 
its proteolytic activity (in a caspase-independent 
fashion) (Saelens et al., 2004). Several studies have 
demonstrated that overexpression of Omi/HtrA2 
markedly  increases  apoptosis  (Kim  et  al.,  2010; 
Tun et al., 2007). In this study, we demonstrated 
that postasphyxial serum incubation can signifi-
cantly induce apoptosis in human HK-2 cells and 
that this effect is mediated by overexpression and 
Fig. 5. The effect of postasphyxial serum on apoptosis in HK-2 cells. HK-2 cell apoptosis was detected by flow cytometry. The proportion 
of cells undergoing apoptosis is small in the control group (Fig.  5A).The proportion of cells undergoing apoptosis increased significantly 
in the postasphyxial serum-attacking group (Fig. 5B). Relative to the postasphyxial serum-attacking group, the proportion of cells un-
dergoing apoptosis decreased significantly in the group treated with ucf-101 (Fig. 5C).
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mitochondrial release of the Omi/HtrA2 protein 
into cytoplasm. 
Omi/HtrA2 is a member of the HtrA family of 
serine proteases, which shows extensive homology to 
the Escherichia coli HtrA genes that are essential for 
bacterial survival at high temperatures. The serine 
protease Omi/HtrA2 is synthesized as a precursor 
(premature Omi/HtrA2) and translocated into the 
mitochondria. Upon apoptotic stimuli, the N-termi-
nal amino acids preceding alanine 134 are cleaved 
and  the  resulting  mature  Omi/HtrA2  is  released 
from the mitochondria into the cytoplasm, where it 
induces apoptosis (Suzuki et al., 2004). Transcription 
of Omi/HtrA2 has been shown to be upregulated in 
ischemic  human  kidneys.  The  enzymatic  activity 
of Omi/HtrA2 is substantially enhanced ischemic/
reperfusing  mouse  kidneys  (Faccio  et  al.,  2000). 
Here, we demonstrated that Omi/HtrA2 was overex-
pressed in HK-2 cells after these cells are attacked by 
postasphyxial serum. Arnold Levine and colleagues 
have identified Omi/HtrA2 as a p53-targeted gene 
(Jin et al., 2003). Kelly et al. reported that p53 pro-
tein levels increase significantly in the kidney over 24 
h post-ischemia (Kelly et al., 2003). In postasphyxial 
serum-treated HK-2 cells, activation of the p53 pro-
tein increases the transcription of the Omi/HtrA2 
gene. 
The key step in the role that Omi/HtrA2 plays 
in postasphyxial serum-induced HK-2 cell apoptosis 
is its release from the mitochondrial intermembrane 
space. After I/R injury, Ca2+ influx through the L-
type calcium channel triggers Ca2+ release from the 
InsP3R, which activates a cascade of Ca2+ release 
from the ER storage area (Wu et al., 2008). However, 
in  ischemia/reperfusion  injuries,  severe  depletion 
of  ATP  leads  to  failure  of  the  pump-leak  balance 
mechanism, leading to an influx of Na+ that results 
in overload of Na+ in the cytosol. This increased Na+ 
level activates Na+-K+-ATPase and consumes ATP, 
which further activates nonselective Ca2+ channels, 
resulting in massive cytosolic Ca2+ accumulation. 
Increased  cytoplasmic  Ca2+  may  activate  calpain, 
and calpain can cleave Bid (Chen et al., 2001b). Af-
ter cleavage, the truncated C-terminal portion of Bid 
(tBid) translocates to the mitochondria and is in-
serted into the outer membrane via its tail. It then 
binds to Bax, facilitating its insertion into the outer 
mitochondrial membrane and creates pores (Eskes et 
al., 2000). In addition, monomeric Bax and tBID to-
gether can induce lipid remodeling following the per-
meabilization of the outer mitochondrial membrane 
(Kuwana et al., 2002). Furthermore, full-length Bid 
may directly translocate to the mitochondria, where 
it may cause effects similar to those of Bax (Pei et al., 
2007; Verhagen et al., 2002). As the permeability of 
Fig. 6. The effect of postasphyxial serum on the expression of Omi/HtrA2 in HK-2 cells. The expression of caspase-3 was detected by SP 
immunocytochemical staining. The proportion of the cells expressing caspase-3 was small in the control group (Fig. 6A). After postas-
phyxial serum challenge, the percentage of cells expressing caspase-3 increased remarkably, as shown in this image of the postasphyxial 
serum-attacking group (Fig. 6B). After ucf-101 treatment, the percentage of cells expressing caspase-3 decreased remarkably (Fig. 6C) 
but not to the level of the control group. 
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the outer mitochondrial membrane increases, Omi/
HtrA2 is released from the mitochondria to the cy-
toplasm.
TNF-α may also play an important role in the 
translocation of Omi/HtrA2 from the mitochon-
dria  to  the  cytoplasm.  In  renal  ischemia/reper-
fusion,  TNF-α  gene  transcription  is  primarily 
regulated by NF-κB activation (Donnahoo et al., 
2000). Usually, NF-κB is localized in the cytoplasm 
in an inactive state due to its association with a 
class of inhibitory proteins termed inhibitory κB 
(IκB). During cellular ischemia/reperfusion injury, 
phosphorylation and subsequent ubiquitination of 
IκB leads to the release and nuclear translocation 
of NF-kB, where it promotes the transcription of 
genes such as TNF-α (Chen et al., 2001a). Recent 
studies have demonstrated that TNF-α involves a 
sequential signaling complex termed “complex I,” 
which contains TNFR-associated factor 2 (TRAF2) 
and promotes the activation of the cytoprotective 
transcription factor NF-κB (Micheau and Tschopp, 
2003). When NF-κB is activated by complex I, a 
positive feedback for TNF-α gene transcription is 
formed.  On  one  hand,  TNF-α-induced  oxidative 
stress  alters  redox  homeostasis  by  impairing  the 
MPTP protein adenine nucleotide translocator and 
voltage-dependent anion channel, thereby result-
ing in the opening of pores and inducing the re-
lease of Omi/HtrA2 (Mariappan et al., 2007). On 
the other hand, the increased TNF-α level in the 
cytosol  activates  caspase-8,  a  proximal  effector 
protein  from  the  tumor  necrosis  factor  receptor 
family. Even small amounts of activated caspase-8 
are able to cleave Bid efficiently, the truncated form 
of which translocates to mitochondria and induces 
the release of Omi/HtrA2 through the mechanism 
described above.   
After  being  released  from  the  mitochondria, 
Omi/HtrA2 may play an important role in apoptosis 
by means of binding and cleaving IAP proteins and 
relieving their inhibitory effect on caspases (Verhagen 
et al., 2007; Yang et al., 2003). The protease activity 
of Omi/HtrA2 is central to its function. Ucf-101, a 
specific Omi/HtrA2 inhibitor, is able to inhibit the 
protease activity of Omi/HtrA2 (Kim et al., 2010). 
Here we report that HK-2 cells treated with ucf-101 
are resistant to postasphyxial serum-induced cell ap-
optosis. Our data demonstrate that Omi/HtrA2 plays 
a  significant  role  in  postasphyxial  serum-induced 
HK-2 cell apoptosis and that its serine protease ac-
tivity is necessary and essential for its proapoptotic 
function in this system. The role of Omi/HtrA2 in the 
cytoplasm is associated with caspase-3. Many studies 
have demonstrated that caspase-3 is upregulated in 
organs affected by ischemia/reperfusion injury (Li et 
al., 2008; Teruya et al., 2008). Our results demonstrate 
that the level of expression of caspase-3 is upregu-
lated in HK-2 cells attacked by postasphyxial serum. 
Caspase-3 can also cleave and activate Bid after the 
onset of apoptosis as part of a positive feedback loop 
(Slee et al., 2000). HK-2 cells treated with ucf-101 are 
resistant to postasphyxial serum-induced caspase-3 
expression. Our findings suggest that Omi/HtrA2 is 
associated with the expression of caspase-3 in HK-2 
cells treated with postasphyxial serum. 
Our  studies  suggest  that  Omi/HtrA2  plays  an 
important  role  in  neonatal  postasphyxial  serum-
induced  injury  in  renal  tubular  cells.  After  HK-2 
cells are attacked by neonatal postasphyxial serum, 
Omi/HtrA2 was released from the mitochondria to 
the cytoplasm where it induced caspase-dependent 
apoptosis in HK-2 cells through its proteolytic ac-
tivity. Our findings point to a novel way of relieving 
postasphyxial serum injuries to human kidney cells 
through inhibiting the proteolytic viability of Omi/
HtrA2.
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